Klinische Forschung Dresden GmbH (KFGN) - PRATIA - PPDS

Dresden, Saxony 01069

0 studies enrolling now · 1 studies all time

What they study most

Plaque Psoriasis

Studies at this site

• A Study About How Well TAK-279 Works and Its Safety in Participants With Moderate-to-severe Plaque Psoriasis During 60 Weeks of Treatment With a Withdrawal and Retreatment Period — Completed